Stress, cytokine patterns and susceptibility to disease

Bailliere's Best Practice and Research in Clinical Endocrinology and Metabolism

Volumn 13, Issue 4, 1999, Pages 583-595

  Elenkov, Ilia J ^a   Chrousos, George P ^b  

^a NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES   (United States)

^b EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

Autoimmunity; Cytokines; Inflammation; Interleukin 10; Interleukin 12; Rheumatoid arthritis; Stress; Th1 Th2 cells

Indexed keywords

ADRENALIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CATECHOLAMINE; CORTICOTROPIN RELEASING FACTOR; CYTOKINE; GLUCOCORTICOID; HISTAMINE; INTERLEUKIN 10; INTERLEUKIN 12; PROPRANOLOL DERIVATIVE; SALBUTAMOL;

ALLERGY; ANIMAL EXPERIMENT; ANIMAL MODEL; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CELLULAR IMMUNITY; CYTOKINE RELEASE; DISEASE PREDISPOSITION; HELICOBACTER PYLORI; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN RHINOVIRUS; HUMORAL IMMUNITY; IMMUNE DEFICIENCY; IMMUNOREGULATION; INFECTION; INFLAMMATION; INJURY; MAST CELL; MYCOBACTERIUM TUBERCULOSIS; NEOPLASM; NONHUMAN; RAT; REVIEW; STRESS; TH1 CELL; TH2 CELL;

EID: 0033509780     PISSN: 1521690X     EISSN: None     Source Type: Journal    
DOI: 10.1053/beem.1999.0045     Document Type: Article

References (53)

1. Chrousos G P. The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. New England Journal of Medicine. 332:1995;1351-1362.
2. Besedovsky H, Del R A, Sorkin E, Dinarello C A. Immunoregulatory feedback between interleukin-1 and glucocorticoid hormones. Science. 233:1986;652-654.
3. Kovacs K J, Elenkov I J. Differential dependence of ACTH secretion induced by various cytokines on the integrity of the paraventricular nucleus. Journal of Neuroendocrinology. 7:1995;15-23.
4. Fearon D T, Locksley R M. The instructive role of innate immunity in the acquired immune response. Science. 272:1996;50-53.
5. Mosmann T R, Sad S. The expanding universe of T-cell subsets: Th1, Th2 and more. Immunology Today. 17:1996;138-146.
6. Trinchieri G. Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annual Reviews of Immunology. 13:1995;251-276.
7. Elenkov I J, Papanicolaou D A, Wilder R L, Chrousos G P. Modulatory effects of glucocorticoids and catecholamines on human interleukin-12 and interleukin-10 production: clinical implications. Proceedings of the Association of American Physicians. 108:1996;374-381.
8. +lymphocytes. Journal of Immunology. 158:1997;5589-5595.
9. +lymphocytes by inhibiting IL-12 production. Journal of Immunology. 160:1998;2231-2237.
10. Wu C Y, Wang K, McDyer J F, Seder R A. Prostaglandin E2 and dexamethasone inhibit IL-12 receptor expression and IL-12 responsiveness. Journal of Immunology. 161:1998;2723-2730.
11. van der Poll T, Barber A E, Coyle S M, Lowry S F. Hypercortisolemia increases plasma interleukin-10 concentrations during human endotoxemia - a clinical research center study. Journal of Clinical Endocrinology and Metabolism. 81:1996;3604-3606.
12. +T cells in vitro. Journal of Immunology. 156:1996;2406-2412.
13. Tabardel Y, Duchateau J, Schmartz D. Corticosteroids increase blood interleukin-10 levels during cardiopulmonary bypass in men. Surgery. 119:1996;76-80.
14. Gayo A, Mozo L, Suarez A. Glucocorticoids increase IL-10 expression in multiple sclerosis patients with acute relapse. Journal of Neuroimmunology. 85:1998;122-130.
15. Panina-Bordignon P, Mazzeo D, Lucia P D. Beta2-agonists prevent Th1 development by selective inhibition of interleukin 12. Journal of Clinical Investigation. 100:1997;1513-1519.
16. Hasko G, Szabo C, Nemeth Z H. Stimulation of beta-adrenoceptors inhibits endotoxin-induced IL-12 production in normal and IL-10 deficient mice. Journal of Neuroimmunology. 88:1998;57-61.
17. Sanders V M, Baker R A, Ramer-Quinn D S. Differential expression of the beta2-adrenergic receptor by Th1 and Th2 clones: implications for cytokine production and B cell help. Journal of Immunology. 158:1997;4200-4210.
18. Borger P, Hoekstra Y, Esselink M T. Beta-adrenoceptor-mediated inhibition of IFN-gamma, IL-3, and GM-CSF mRNA accumulation in activated human T lymphocytes is solely mediated by the beta2-adrenoceptor subtype. American Journal of Respiratory and Cell Molecular Biology. 19:1998;400-407.
19. Hasko G, Elenkov I J, Kvetan V, Vizi E S. Differential effect of selective block of alpha 2-adrenoreceptors on plasma levels of tumour necrosis factor-alpha, interleukin-6 and corticosterone induced by bacterial lipopolysaccharide in mice. Journal of Endocrinology. 144:1995;457-462.
20. Elenkov I J, Hasko G, Kovacs K J, Vizi E S. Modulation of lipopolysaccharide-induced tumor necrosis factor-alpha production by selective alpha- and beta-adrenergic drugs in mice. Journal of Neuroimmunology. 61:1995;123-131.
21. Woiciechowsky C, Asadullah K, Nestler D. Sympathetic activation triggers systemic interleukin-10 release in immunodepression induced by brain injury. Nature Medicine. 4:1998;808-813.
22. Karalis K, Sano H, Redwine J. Autocrine or paracrine inflammatory actions of corticotropin-releasing hormone in vivo. Science. 254:1991;421-423.
23. Elenkov I J, Webster E L, Torpy D J, Chrousos G P. Stress, corticotropin-releasing hormone, glucocorticoids, and the immune/inflammatory response: acute and chronic effects. Annals of the New York Academy of Sciences. 876:1999;1-13.
24. Theoharides T C, Spanos C, Pang X. Stress-induced intracranial mast cell degranulation: a corticotropin-releasing hormone-mediated effect. Endocrinology. 136:1995;5745-5750.
25. Udelsman R, Gallucci W T, Bacher J. Hemodynamic effects of corticotropin releasing hormone in the anesthetized cynomolgus monkey. Peptides. 7:1986;465-471.
26. Theoharides T C, Singh L K, Boucher W. Corticotropin-releasing hormone induces skin mast cell degranulation and increased vascular permeability, a possible explanation for its proinflammatory effects. Endocrinology. 139:1998;403-413.
27. Elenkov I J, Webster E, Papanicolaou D A. Histamine potently suppresses human IL-12 and stimulates IL-10 production via H2 receptors. Journal of Immunology. 161:1998;2586-2593.
28. Lagier B, Lebel B, Bousquet J, Pene J. Different modulation by histamine of IL-4 and interferon-gamma (IFN-gamma) release according to the phenotype of human Th0, Th1 and Th2 clones. Clinical and Experimental Immunology. 108:1997;545-551.
29. Elenkov I J, Chrousos G P. Stress hormones, Th1/Th2 patterns, pro/anti-inflammatory cytokines and susceptibility to disease. Trends in Endocrinology and Metabolism. 10:1999;359-368.
30. Altare F, Durandy A, Lammas D. Impairment of mycobacterial immunity in human interleukin-12 receptor deficiency. Science. 280:1998;1432-1435.
31. Lerner B H. Can stress cause disease? Revisiting the tuberculosis research of Thomas Holmes, 1949-1961. Annals of Internal Medicine. 124:1996;673-680.
32. Elenkov I J, Vizi E S. Presynaptic modulation of release of noradrenaline from the sympathetic nerve terminals in the rat spleen. Neuropharmacology. 30:1991;1319-1324.
33. Vizi E S, Orso E, Osipenko O N. Neurochemical, electrophysiological and immunocytochemical evidence for a noradrenergic link between the sympathetic nervous system and thymocytes. Neuroscience. 68:1995;1263-1276.
34. Cole S W, Korin Y D, Fahey J L, Zack J A. Norepinephrine accelerates HIV replication via protein kinase A-dependent effects on cytokine production. Journal of Immunology. 161:1998;610-616.
35. Haraguchi S, Good R A, James-Yarish M. Differential modulation of Th1- and Th2-related cytokine mRNA expression by a synthetic peptide homologous to a conserved domain within retroviral envelope protein. Proceedings of the National Academy of Sciences USA. 92:1995;3611-3615.
36. Clerici M, Bevilacqua M, Vago T. An immunoendocrinological hypothesis of HIV infection. Lancet. 343:1994;1552-1553.
37. Kino T, Gragerov A, Kopp J B. The HIV-1 virion-associated protein vpr is a coactivator of the human glucocorticoid receptor. Journal of Experimental Medicine. 189:1999;51-62.
38. Cohen S, Tyrrell D A, Smith A P. Psychological stress and susceptibility to the common cold. New England Journal of Medicine. 325:1991;606-612.
39. O'Sullivan S T, Lederer J A, Horgan A F. Major injury leads to predominance of the T helper-2 lymphocyte phenotype and diminished interleukin-12 production associated with decreased resistance to infection. Annals of Surgery. 222:1995;482-490.
40. Segal B M, Dwyer B K, Shevach E M. An interleukin (IL)-10/IL-12 immunoregulatory circuit controls susceptibility to autoimmune disease. Journal of Experimental Medicine. 187:1998;537-546.
41. Rogers M P, Fozdar M. Psychoneuroimmunology of autoimmune disorders. Advances in Neuroimmunology. 6:1996;169-177.
42. Wilder R L. Neuroendocrine-immune system interactions and autoimmunity. Annual Reviews of Immunology. 13:1995;307-338.
43. Elenkov I J, Hoffman J, Wilder R L. Does differential neuroendocrine control of cytokine production govern the expression of autoimmune diseases in pregnancy and the postpartum period? Molecular Medicine Today. 3:1997;379-383.
44. Horwitz M S, Bradley L M, Harbertson J. Diabetes induced by Coxsackie virus: initiation by bystander damage and not molecular mimicry. Nature Medicine. 4:1998;781-785.
45. Takahashi Y, Murai C, Shibata S. Human parvovirus B19 as a causative agent for rheumatoid arthritis. Proceedings of the National Academy of Sciences of the USA. 95:1998;8227-8232.
46. Barnes P, FitzGerald G, Brown M, Dollery C. Nocturnal asthma and changes in circulating epinephrine, histamine, and cortisol. New England Journal of Medicine. 303:1980;263-267.
47. Zieg G, Lack G, Harbeck R J. In vivo effects of glucocorticoids on IgE production. Journal of Allergy and Clinical Immunology. 94:1994;222-230.
48. Coqueret O, Dugas B, Mencia-Huerta J M, Braquet P. Regulation of IgE production from human mononuclear cells by beta 2-adrenoceptor agonists. Clinical and Experimental Allergy. 25:1995;304-311.
49. Colombo M P, Vagliani M, Spreafico F. Amount of interleukin 12 available at the tumor site is critical for tumor regression. Cancer Research. 56:1996;2531-2534.
50. Chouaib S, Asselin-Paturel C, Mami-Chouaib F. The host-tumor immune conflict: from immunosuppression to resistance and destruction. Immunology Today. 18:1997;493-497.
51. Shakhar G, Ben-Eliyahu S. In vivo beta-adrenergic stimulation suppresses natural killer activity and compromises resistance to tumor metastasis in rats. Journal of Immunology. 160:1998;3251-3258.
52. +T cells. Anticancer Research. 17:1997;4259-4268.
53. Matsumoto S. Cimetidine and survival with colorectal cancer. Lancet. 346:1995;115.